Home Featured Page 272

Featured

Latest

Pα+ Psychedelic Bulletin #204: FDA Keeps GH Research’s 5-MeO-DMT on Ice; Makary’s Priority Voucher Pilot Launches, Mentions Innovative PTSD Treatments; HALT Fentanyl Act Could...

June 2025 Psychedelic Patent Update

Alan Davis – Psychedelic Research and Patient Safety at Ohio State & Exploring Ibogaine’s Potential

Dispatch: The Neurobiology of Psychedelics Gordon Research Conference — Plasticity, Psychotherapy, and Perception (Part 1)

Karina Bashir on Psychedelics, Islam, and Human Rights

PT233 – JR Rahn of MindMed – LSD, ADHD, and Decriminalization

Numinus and Syreon Provide Psilocybin Compassionate Access Trial Update

Psyched Wellness Provides Update on Pre-Clinical Trial of Its Muscimol Extract...

MINDCURE Completes Its Initial Strategic Equity Investment in ATMA, Canada’s First...

COMPASS Pathways plc to announce fourth quarter and full year 2020...

PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine...

NeonMind Files Four Additional Provisional Patents on Psilocybin Preclinical Data

Psychedelics Company Silo Wellness Inc. (Formerly Yukoterre Resources Inc.) Announces Successful...

Finding the Psychedelic Sweet Spot

Novamind Reports Company Highlights and Strong Revenue Growth in Fiscal Second...

1...271272273...293 Page 272 of 293

Pα+ Psychedelic Bulletin #204: FDA Keeps GH Research’s 5-MeO-DMT on Ice;...

June 2025 Psychedelic Patent Update

Alan Davis – Psychedelic Research and Patient Safety at Ohio State...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Pα+ Psychedelic Bulletin #204: FDA Keeps GH Research’s 5-MeO-DMT on Ice; Makary’s Priority Voucher Pilot Launches, Mentions Innovative PTSD Treatments; HALT Fentanyl Act Could...

June 2025 Psychedelic Patent Update

Alan Davis – Psychedelic Research and Patient Safety at Ohio State & Exploring Ibogaine’s Potential

Dispatch: The Neurobiology of Psychedelics Gordon Research Conference — Plasticity, Psychotherapy, and Perception (Part 1)

Karina Bashir on Psychedelics, Islam, and Human Rights

PT233 – JR Rahn of MindMed – LSD, ADHD, and Decriminalization

Numinus and Syreon Provide Psilocybin Compassionate Access Trial Update

Psyched Wellness Provides Update on Pre-Clinical Trial of Its Muscimol Extract...

MINDCURE Completes Its Initial Strategic Equity Investment in ATMA, Canada’s First...

COMPASS Pathways plc to announce fourth quarter and full year 2020...

PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine...

NeonMind Files Four Additional Provisional Patents on Psilocybin Preclinical Data

Psychedelics Company Silo Wellness Inc. (Formerly Yukoterre Resources Inc.) Announces Successful...

Finding the Psychedelic Sweet Spot

Novamind Reports Company Highlights and Strong Revenue Growth in Fiscal Second...

EDITOR PICKS

Pα+ Psychedelic Bulletin #204: FDA Keeps GH Research’s 5-MeO-DMT on Ice;...

June 2025 Psychedelic Patent Update

Alan Davis – Psychedelic Research and Patient Safety at Ohio State...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY